|
|
||||||||
Ann Thorac Surg 2004;78:1888
© 2004 The Society of Thoracic Surgeons
a Transplantation Biology Research Center, Massachusetts General Hospital, 13th St, Bldg 149, Charlestown, MA, 02129, USA
b Department of General and Thoracic Surgery, Justus-Liebig University of Gießen, Rudolf-Buchheim Str. 7, 35392 Gießen, Germany
ruediger.hoerbelt{at}tbrc.mgh.harvard.edu
To the Editor:
We agree with Dr Koduri that lymphoblastic lymphoma can be diagnosed in one third of patients by bone marrow biopsy, whichif positivecan obviate surgical biopsy of the mediastinal tumor. In our study [1], we focused on the differentiation between nonlymphatic and lymphatic mediastinal tumors. The further distinction between subtypes of malignant lymphoma was beyond the scope of our investigation. In patients with lymphoblastic lymphoma, a leukemic phase that is similar to acute lymphatic leukemia often develops [2], and therefore, the primary diagnostic approach varies from the usual excisional biopsy of the affected lymph node. We agree that bone marrow biopsy should be performed prior to operation in young patients with a mediastinal mass in whom atypical blast cells are seen in the peripheral blood.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |